Tag: new-medicines
-
Child TB deaths set to fall as Kenya launches new drugs
By Katy Migiro NAIROBI (Thomson Reuters Foundation) – More children are likely to survive tuberculosis, the leading infectious disease killer, after Kenya introduces child-friendly medicines on Oct. 1 – the first country in the world to do so. Some 155,000 children with TB are set to benefit across 18 countries that have already ordered the…
-
Child TB deaths set to fall as Kenya launches new drugs
By Katy Migiro NAIROBI (Thomson Reuters Foundation) – More children are likely to survive tuberculosis, the leading infectious disease killer, after Kenya introduces child-friendly medicines on Oct. 1 – the first country in the world to do so. Some 155,000 children with TB are set to benefit across 18 countries that have already ordered the…
-
Mother sues U.S. hospital for discriminating against dead transgender son
The mother of a transgender boy filed a lawsuit against a U.S. hospital on Monday claiming its medical staff repeatedly addressed her son – who later committed suicide – as a girl. In the landmark case, Katharine Prescott argues the Rady Children’s Hospital-San Diego (RCHSD) in California discriminated against her transgender son based on his…
-
Mother sues U.S. hospital for discriminating against dead transgender son
The mother of a transgender boy filed a lawsuit against a U.S. hospital on Monday claiming its medical staff repeatedly addressed her son – who later committed suicide – as a girl. In the landmark case, Katharine Prescott argues the Rady Children’s Hospital-San Diego (RCHSD) in California discriminated against her transgender son based on his…
-
Cancer patients may be overly optimistic about early drug trial participation
By Andrew M. Seaman (Reuters Health) – People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K. So-called phase 1 trials of experimental treatments are intended to…
-
Cancer patients may be overly optimistic about early drug trial participation
By Andrew M. Seaman (Reuters Health) – People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K. So-called phase 1 trials of experimental treatments are intended to…
-
Kite immunotherapy drug helps blood cancer patients in study
(Reuters) – Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial. Shares of Kite, which had been halted before the release of…